{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:17:58Z","timestamp":1777886278452,"version":"3.51.4"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ECS00000041-VITALITY-D73C22000840006"],"award-info":[{"award-number":["ECS00000041-VITALITY-D73C22000840006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ahjo.2026.100782","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:23:21Z","timestamp":1775755401000},"page":"100782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Significance of 8-iso-PGF2\u03b1 in cardiovascular diseases"],"prefix":"10.1016","volume":"65","author":[{"given":"Paola","family":"Simeone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Liani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Alfonsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cipollone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahjo.2026.100782_bb0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1080\/10715760701732830","article-title":"Microcirculation and oxidative stress","volume":"41","author":"Crimi","year":"2007","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0010","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3109\/10715762.2010.498477","article-title":"Chemistry and biochemistry of lipid peroxidation products","volume":"44","author":"Gu\u00e9raud","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000063","article-title":"Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype","volume":"2","author":"Vazzana","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100782_bb0020","series-title":"Isoprostanes: potential markers of oxidant stress in atherothrombotic disease","author":"Patrono","year":"1997"},{"key":"10.1016\/j.ahjo.2026.100782_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free radicals: properties, sources, targets, and their implication in various diseases","volume":"30","author":"Phaniendra","year":"2015","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0030","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.R113.472936","article-title":"Peroxynitrite, a stealthy biological oxidant","volume":"288","author":"Radi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbt.10058","article-title":"Diabetes, oxidative stress, and antioxidants: a review","volume":"17","author":"Maritim","year":"2003","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2020.04.006","article-title":"Urinary 8-isoprostane as a biomarker for oxidative stress. A systematic review and meta-analysis","volume":"328","author":"Graille","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ahjo.2026.100782_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000490669","article-title":"Genetic factors and molecular mechanisms of vitamin D and obesity relationship","volume":"73","author":"Ruiz-Ojeda","year":"2018","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.ahjo.2026.100782_bb0050","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ahjo.2026.100782_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0090-6980(97)00004-X","article-title":"Effect of the isoprostanes, 8-iso prostaglandin E2 and 8-iso prostaglandin F2\u03b1 on the rabbit lung in vivo","volume":"53","author":"Hill","year":"1997","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ahjo.2026.100782_bb0060","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2008.03.014","article-title":"Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF2\u03b1 with the thromboxane A2 receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets","volume":"75","author":"Khasawneh","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0065","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","article-title":"Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo","volume":"274","author":"Lawson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.05.017","article-title":"Arterial stiffness and sedentary lifestyle: role of oxidative stress","volume":"79","author":"Lessiani","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5534\/wjmh.16032","article-title":"The correlation between body mass index and routine parameters in men over fifty","volume":"35","author":"Seo","year":"2017","journal-title":"world J Mens Health"},{"key":"10.1016\/j.ahjo.2026.100782_bb0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11745-999-0397-1","article-title":"Elevated plasma levels of F2\u03b1 isoprostane in cystic fibrosis","volume":"34","author":"Collins","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.ahjo.2026.100782_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(98)90124-7","article-title":"Role of 8-epi PGF2\u03b1, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function","volume":"58","author":"Hart","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ahjo.2026.100782_bb0095","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199006213222503","article-title":"Thromboxane biosynthesis and platelet function in type II diabetes mellitus","volume":"322","author":"Dav\u00ec","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ahjo.2026.100782_bb0105","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1074\/jbc.271.25.14916","article-title":"Local amplification of platelet function by 8-epi prostaglandin F2\u03b1 is not mediated by thromboxane receptor isoforms","volume":"271","author":"Pratic\u00f2","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0110","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/01.CIR.101.24.2833","article-title":"Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane a(2) receptor in vivo","volume":"101","author":"Audoly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0115","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Dav\u00ec","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahjo.2026.100782_bb0120","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.ATV.17.11.3230","article-title":"In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia","volume":"17","author":"Davi","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0125","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/01.CIR.0000074205.17807.D0","article-title":"Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration","volume":"107","author":"Dav\u00ec","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Dav\u00ec","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0135","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/hc3501.095287","article-title":"Oxidative stress and platelet activation in homozygous homocystinuria","volume":"104","author":"Dav\u00ec","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1160\/TH16-02-0167","article-title":"Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-\u03b1 treatment","volume":"116","author":"Sabatino","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0145","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0891-5849(91)90073-C","article-title":"Noninvasive measures of oxidative stress status in humans","volume":"10","author":"Pryor","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02255929","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation: an overview","volume":"5","author":"Liu","year":"1998","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ahjo.2026.100782_bb0160","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.freeradbiomed.2007.06.017","article-title":"Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins","volume":"43","author":"Santilli","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000198","article-title":"IPINET group, relationship between platelet and urinary 8-Iso-PGF2\u03b1 levels in subjects with different degrees of NOX2 regulation","volume":"2","author":"Carnevale","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100782_bb0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fasebj.13.9.1025","article-title":"Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release","volume":"13","author":"Jourdan","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10715769809065821","article-title":"Measurement of lipid peroxidation","volume":"28","author":"Moore","year":"1998","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0180","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/0929867033457115","article-title":"The Isoprostanes: unique products of arachidonic acid oxidation-a review","volume":"10","author":"Fam","year":"2003","journal-title":"CMC"},{"key":"10.1016\/j.ahjo.2026.100782_bb0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)12087-9","article-title":"Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man","volume":"275","author":"Wang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ahjo.2026.100782_bb0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0952-3278(98)90042-4","article-title":"Radioimmunosassay of 8-iso-prostaglandin F2\u03b1: an index for oxidative injury via free radical catalysed lipid peroxidation","volume":"58","author":"Basu","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ahjo.2026.100782_bb0195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.coph.2004.11.003","article-title":"Isoprostane formation and inhibition in atherothrombosis","volume":"5","author":"Patrono","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0200","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.ATV.18.8.1248","article-title":"The F2 -Isoprostane 8-Epiprostaglandin F2\u03b1 increases platelet adhesion and reduces the antiadhesive and Antiaggregatory effects of NO","volume":"18","author":"Minuz","year":"1998","journal-title":"ATVB"},{"key":"10.1016\/j.ahjo.2026.100782_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(99)00257-9","article-title":"F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo","volume":"147","author":"Pratic\u00f2","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahjo.2026.100782_bb0210","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.21037\/atm-20-7197","article-title":"New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: a narrative review","volume":"9","author":"Migdalski","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0215","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI119735","article-title":"Localization of distinct F2-isoprostanes in human atherosclerotic lesions","volume":"100","author":"Pratic\u00f2","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ahjo.2026.100782_bb0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1179\/135100008X259204","article-title":"Markers of oxidative damage in chronic heart failure: role in disease progression","volume":"13","author":"Radovanovic","year":"2008","journal-title":"Redox Rep."},{"key":"10.1016\/j.ahjo.2026.100782_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/HYPERTENSIONAHA.107.099986","article-title":"The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans","volume":"51","author":"Lavi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ahjo.2026.100782_bb0230","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.CIR.102.9.1007","article-title":"Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina","volume":"102","author":"Cipollone","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0235","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1161\/01.CIR.95.11.2492","article-title":"8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo","volume":"95","author":"Delanty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0240","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0022-5223(03)00794-3","article-title":"The relationship between plasma free 15-F2t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery","volume":"126","author":"Ansley","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ahjo.2026.100782_bb0245","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000903","article-title":"Circulating myeloid-related protein-8\/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment","volume":"3","author":"Santilli","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100782_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8418820","article-title":"The role of oxidative stress in acute ischemic stroke-related thrombosis","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ahjo.2026.100782_bb0255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/ATVBAHA.110.217885","article-title":"Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction","volume":"31","author":"Pignatelli","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0260","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1155\/2013\/530946","article-title":"Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease","volume":"35","author":"Strzy\u017cewski","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ahjo.2026.100782_bb0265","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jvs.2004.07.044","article-title":"Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease","volume":"40","author":"Mueller","year":"2004","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ahjo.2026.100782_bb0270","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1074\/jbc.R700047200","article-title":"Human biochemistry of the isoprostane pathway","volume":"283","author":"Milne","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.freeradbiomed.2016.07.011","article-title":"Biochemical indices of oxidative stress and inflammation in the evaluation of peripheral artery disease","volume":"97","author":"Fort-Gallifa","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001072","article-title":"Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease","volume":"3","author":"Loffredo","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2026.100782_bb0285","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jvs.2012.05.064","article-title":"Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication","volume":"56","author":"Gresele","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ahjo.2026.100782_bb0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1160\/TH10-07-0499","article-title":"Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost","volume":"105","author":"Lessiani","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/138920106776597658","article-title":"Oxidative stress, endothelial function and angiogenesis induced by cell therapy and gene therapy","volume":"7","author":"Higashi","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0300","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1074\/jbc.270.17.9800","article-title":"Cylooxygenase-dependent formation of the Isoprostane, 8-epi prostaglandin F2\u03b1","volume":"270","author":"Pratico","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1373\/clinchem.2004.037630","article-title":"Plasma F2-Isoprostanes and coronary artery calcification: the CARDIA study","volume":"51","author":"Gross","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251308","article-title":"Biomarkers representing key aging-related biological pathways are associated with subclinical atherosclerosis and all-cause mortality: the Framingham study","volume":"16","author":"Castro-Diehl","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.ahjo.2026.100782_bb0315","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1538-7836.2010.03820.x","article-title":"Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment","volume":"8","author":"Santilli","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.mca.0000063504.13456.c3","article-title":"Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease","volume":"14","author":"Vassalle","year":"2003","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ahjo.2026.100782_bb0325","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/CCLM.2009.069","article-title":"Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers","volume":"47","author":"Lowe","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0330","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/1354750X.2014.912354","article-title":"A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers","volume":"19","author":"Haswell","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.ahjo.2026.100782_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxrep.2018.11.011","article-title":"Influence of smoking on levels of urinary 8-iso prostaglandin F2\u03b1","volume":"6","author":"van der Plas","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.ahjo.2026.100782_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","article-title":"Modulation of oxidant stress in vivo in chronic cigarette smokers","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2014.03.009","article-title":"Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension","volume":"433","author":"de Faria","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ahjo.2026.100782_bb0350","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000450562","article-title":"Blood pressure reduction is associated with the changes in oxidative stress and endothelial activation in hypertension, regardless of antihypertensive therapy","volume":"41","author":"Mihalj","year":"2016","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0355","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/10641960802071000","article-title":"Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension","volume":"30","author":"Hirooka","year":"2008","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ahjo.2026.100782_bb0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.med.52.1.421","article-title":"Renal artery stenosis: a common, treatable cause of renal failure?","volume":"52","author":"Textor","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0365","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","article-title":"Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease","volume":"106","author":"Minuz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0370","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.freeradbiomed.2009.01.005","article-title":"Determinants of platelet activation in hypertensives with microalbuminuria","volume":"46","author":"Guagnano","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0375","first-page":"99","article-title":"The link between chronic kidney disease and cardiovascular disease","volume":"3","author":"Said","year":"2014","journal-title":"J. Nephropathol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0380","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ahjo.2026.100782_bb0385","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jpeds.2012.05.042","article-title":"Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction","volume":"161","author":"Loffredo","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0390","doi-asserted-by":"crossref","first-page":"E1726","DOI":"10.1210\/jc.2012-1473","article-title":"Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress","volume":"97","author":"Vazzana","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ahjo.2026.100782_bb0395","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/nu10121872","article-title":"Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: effects of Liraglutide- or lifestyle changes-induced weight loss","volume":"10","author":"Simeone","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ahjo.2026.100782_bb0400","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.2174\/092986711798184299","article-title":"Determinants of increased cardiovascular disease in obesity and metabolic syndrome","volume":"18","author":"Vazzana","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0405","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/oby.2011.58","article-title":"Reduction of 8-iso-prostaglandin F2\u03b1 in the first week after roux-en-Y gastric bypass surgery","volume":"19","author":"Ueda","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ahjo.2026.100782_bb0410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamasurg.2014.1682","article-title":"Thromboxane-dependent platelet activation after gastric banding for obesity","volume":"150","author":"Vazzana","year":"2015","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ahjo.2026.100782_bb0415","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0026-0495(91)90005-H","article-title":"Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients","volume":"40","author":"Lavy","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/j.ahjo.2026.100782_bb0420","first-page":"527","article-title":"The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients","volume":"10","author":"Cominacini","year":"1994","journal-title":"Nutrition"},{"key":"10.1016\/j.ahjo.2026.100782_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-6980(92)90077-7","article-title":"The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane\/endoperoxide receptor, is a platelet thromboxane\/endoperoxide receptor antagonist","volume":"44","author":"Morrow","year":"1992","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ahjo.2026.100782_bb0430","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2796.2007.01784.x","article-title":"Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects","volume":"261","author":"Mangiafico","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0435","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.ATV.0000152605.64964.c0","article-title":"Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans","volume":"25","author":"Morrow","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0440","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.98.25.2822","article-title":"Increased formation of distinct F2 isoprostanes in hypercholesterolemia","volume":"98","author":"Reilly","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0445","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1196\/annals.1331.029","article-title":"Vitamin E for the treatment of cardiovascular disease: is there a future?","volume":"1031","author":"Violi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ahjo.2026.100782_bb0450","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.08.041","article-title":"LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism","volume":"237","author":"Carnevale","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahjo.2026.100782_bb0455","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(02)02811-5","article-title":"The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells","volume":"41","author":"Cominacini","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0460","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2010.10.006","article-title":"Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia","volume":"214","author":"Puccetti","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahjo.2026.100782_bb0465","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1089\/ars.2005.7.1040","article-title":"The molecular basis for oxidative stress-induced insulin resistance","volume":"7","author":"Evans","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ahjo.2026.100782_bb0470","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0735-1097(02)02972-8","article-title":"Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus","volume":"41","author":"Gresele","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0475","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","volume":"121","author":"Pignone","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0480","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/diacare.28.7.1690","article-title":"Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy","volume":"28","author":"Chiarelli","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahjo.2026.100782_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3232","article-title":"In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance","volume":"36","author":"Santilli","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ahjo.2026.100782_bb0490","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","article-title":"Platelet activation in type 2 diabetes mellitus","volume":"2","author":"Ferroni","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0495","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/dmrr.962","article-title":"Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept","volume":"25","author":"Monnier","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ahjo.2026.100782_bb0500","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ahjo.2026.100782_bb0505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ahjo.2026.100782_bb0510","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1531003507308791","article-title":"COmmentary: assessment of renal artery stenosis severity by pressure gradient measurements. De Bruyne B, Manoharan G, Pijls NH, et al. J Am Coll Cardiol. 2006;48:1851\u20131855","volume":"19","author":"Modrall","year":"2007","journal-title":"Perspect. Vasc. Surg. Endovasc. Ther."},{"key":"10.1016\/j.ahjo.2026.100782_bb0515","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1538-7836.2010.03742.x","article-title":"Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus","volume":"8","author":"Santilli","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0520","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ahjo.2026.100782_bb0525","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2337\/diacare.28.5.1231","article-title":"Continuous glucose monitoring: roadmap for 21st century diabetes therapy","volume":"28","author":"Klonoff","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahjo.2026.100782_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107911","article-title":"The relationship between glucose variability and insulin sensitivity and oxidative stress in subjects with prediabetes","volume":"158","author":"Dimova","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ahjo.2026.100782_bb0535","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1507\/endocrj.EJ19-0016","article-title":"Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system","volume":"66","author":"Li","year":"2019","journal-title":"Endocr. J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0540","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/513742","article-title":"The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients","volume":"2013","author":"Tuzcu","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ahjo.2026.100782_bb0545","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2005.03.079","article-title":"Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus","volume":"47","author":"Santilli","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0550","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.freeradbiomed.2012.02.012","article-title":"Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients","volume":"52","author":"Liani","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0555","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.freeradbiomed.2007.03.015","article-title":"Soluble RAGE in type 2 diabetes: association with oxidative stress","volume":"43","author":"Devangelio","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0560","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ahjo.2026.100782_bb0565","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH16-06-0471","article-title":"Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus","volume":"116","author":"Santilli","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0570","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2009.05.011","article-title":"REACH registry investigators, renal function, atherothrombosis extent, and outcomes in high-risk patients","volume":"158","author":"Dumaine","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0580","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000066962","article-title":"8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients","volume":"20","author":"Lim","year":"2002","journal-title":"Blood Purif."},{"key":"10.1016\/j.ahjo.2026.100782_bb0590","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/gfn489","article-title":"Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients","volume":"24","author":"Cottone","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ahjo.2026.100782_bb0595","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI115826","article-title":"Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors","volume":"90","author":"Takahashi","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ahjo.2026.100782_bb0600","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1160\/TH08-03-0136","article-title":"Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease","volume":"100","author":"Serebruany","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prostaglandins.2015.05.002","article-title":"Platelets and diabetes mellitus","volume":"120","author":"Santilli","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ahjo.2026.100782_bb0610","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2174\/1381612043384682","article-title":"The role of the platelet glycoprotein IIb\/IIIa in thrombosis and haemostasis","volume":"10","author":"Fullard","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ahjo.2026.100782_bb0615","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11739-010-0440-3","article-title":"TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus","volume":"6","author":"Santilli","year":"2011","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0620","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2009.01.037","article-title":"Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin","volume":"143","author":"Lordkipanidz\u00e9","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0625","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.thromres.2011.12.002","article-title":"Platelet oxidative stress and thrombosis","volume":"129","author":"Violi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0630","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.109.877191","article-title":"Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study","volume":"120","author":"Violi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0635","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.112.000966","article-title":"Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis","volume":"127","author":"Dayal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0640","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCULATIONAHA.112.095554","article-title":"Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2","volume":"126","author":"Pignatelli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0645","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/j.thromres.2013.01.007","article-title":"Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms","volume":"131","author":"Moscard\u00f3","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0650","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2014.12.010","article-title":"Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus","volume":"80","author":"Santilli","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0655","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/db11-1243","article-title":"Platelet isoprostane overproduction in diabetic patients treated with aspirin","volume":"61","author":"Cangemi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ahjo.2026.100782_bb0660","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0665","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/nu9111211","article-title":"Vitamin C and immune function","volume":"9","author":"Carr","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ahjo.2026.100782_bb0670","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcin.2009.10.025","article-title":"Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers","volume":"3","author":"Basili","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ahjo.2026.100782_bb0675","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/10715760410001688339","article-title":"Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release","volume":"38","author":"Berg","year":"2004","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0680","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1993.tb39148.x","article-title":"Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite","volume":"686","author":"Pryor","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ahjo.2026.100782_bb0685","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/77.1.160","article-title":"Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes","volume":"77","author":"Dietrich","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0690","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/07315724.1999.10718880","article-title":"Beta-carotene and other carotenoids as antioxidants","volume":"18","author":"Paiva","year":"1999","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0695","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.freeradbiomed.2016.03.010","article-title":"Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress","volume":"95","author":"Guertin","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0700","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.CIR.102.5.539","article-title":"Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers","volume":"102","author":"Patrignani","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0705","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.3390\/molecules27196613","article-title":"Selenium: an antioxidant with a critical role in anti-aging","volume":"27","author":"Bj\u00f8rklund","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ahjo.2026.100782_bb0710","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ejcn.2015.78","article-title":"Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials","volume":"70","author":"Zhang","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0715","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1016\/S0021-9258(19)39376-7","article-title":"The induction of specific rat liver glutathione S-transferase subunits under inadequate selenium nutrition causes an increase in prostaglandin F2 alpha formation","volume":"265","author":"Chang","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0720","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/10715760500108513","article-title":"Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men","volume":"39","author":"Helmersson","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0725","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2015.03.011","article-title":"Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: vitamin D3 megadose reduces inflammatory markers","volume":"66","author":"de Medeiros Cavalcante","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ahjo.2026.100782_bb0730","first-page":"229","article-title":"Effects of vitamin D and quercetin, alone and in combination, on cardiorespiratory fitness and muscle function in physically active male adults, open access","volume":"6","author":"Scholten","year":"2015","journal-title":"J. Sports Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0735","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2012.12.013","article-title":"Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes","volume":"227","author":"Yiu","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahjo.2026.100782_bb0740","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clnesp.2018.10.004","article-title":"Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: a pilot randomized study","volume":"29","author":"Makariou","year":"2019","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.ahjo.2026.100782_bb0745","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/nbu.12278","article-title":"The role of polyphenols in modern nutrition","volume":"42","author":"Williamson","year":"2017","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.ahjo.2026.100782_bb0750","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2891-10-67","article-title":"Acute reduction of serum 8-iso-PGF2-alpha and advanced oxidation protein products in vivo by a polyphenol-rich beverage; a pilot clinical study with phytochemical and in vitro antioxidant characterization","volume":"10","author":"Nemzer","year":"2011","journal-title":"Nutr. J."},{"key":"10.1016\/j.ahjo.2026.100782_bb0755","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/antiox9020167","article-title":"Cocoa flavonoids reduce inflammation and oxidative stress in a myocardial ischemia-reperfusion experimental model","volume":"9","author":"Ahmed","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ahjo.2026.100782_bb0760","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/antiox9121230","article-title":"Antioxidants in cocoa","volume":"9","author":"Oracz","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ahjo.2026.100782_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102240","article-title":"The effect of cocoa consumption on markers of oxidative stress: a systematic review and meta-analysis of interventional studies","volume":"48","author":"Mehrabani","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0770","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3945\/ajcn.114.092189","article-title":"Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial","volume":"101","author":"Mastroiacovo","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0775","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/CIRCULATIONAHA.107.713867","article-title":"Dark chocolate improves coronary vasomotion and reduces platelet reactivity","volume":"116","author":"Flammer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100782_bb0780","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07315724.2004.10719361","article-title":"Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults","volume":"23","author":"Engler","year":"2004","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0785","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of Omega-6 and Omega-3 polyunsaturated fatty acids on human health: an update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ahjo.2026.100782_bb0790","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"N-3 fatty acids in cardiovascular disease","volume":"364","author":"De Caterina","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb0795","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.ahjo.2026.100782_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104462","article-title":"Omega-3 fatty acids supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials","volume":"149","author":"Heshmati","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0805","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/jn\/136.5.1222","article-title":"Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans","volume":"136","author":"N\u00e4ls\u00e9n","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.ahjo.2026.100782_bb0810","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/10715762.2010.492830","article-title":"The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: results from two placebo-controlled interventions","volume":"44","author":"Mas","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb0815","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1160\/TH11-12-0899","article-title":"Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C\u2192T polymorphism","volume":"108","author":"Dragani","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb0820","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/EBC20190096","article-title":"Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now?","volume":"64","author":"Ahmed","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ahjo.2026.100782_bb0825","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/alz.12081","article-title":"Associations of urinary 8-iso-prostaglandin F2\u03b1 levels with all-cause dementia, Alzheimer\u2019s disease, and vascular dementia incidence: results from a prospective cohort study","volume":"16","author":"Trares","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ahjo.2026.100782_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101552","article-title":"Association of F2-isoprostane levels with Alzheimer\u2019s disease in observational studies: a systematic review and meta-analysis","volume":"74","author":"Trares","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100782_bb3000","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03349310","article-title":"Radioimmunoassay measurement of prostaglandins E2 and F2alpha in human urine","volume":"2","author":"Ciabattoni","year":"1979","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100782_bb3005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1081\/DMR-100101910","article-title":"The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation","volume":"31","author":"Morrow","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ahjo.2026.100782_bb3010","doi-asserted-by":"crossref","unstructured":"GL Milne, ES Musiek, LD Morrow. F2-isoprostanesas markers of oxidative stress in vivo, an overview. Biomarkers Nov;10 Suppl 1: 2005S1023.","DOI":"10.1080\/13547500500216546"},{"issue":"34","key":"10.1016\/j.ahjo.2026.100782_bb3015","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1074\/jbc.271.34.20617","article-title":"Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans","volume":"271","author":"Roberts","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100782_bb3020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.229.45","article-title":"Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome","volume":"229","author":"Li","year":"2013","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ahjo.2026.100782_bb3025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2015.01.043","article-title":"Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort","volume":"183","author":"Lin","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ahjo.2026.100782_bb3030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.26.691","article-title":"Candesartan reduces oxidative stress and inflammation in patients with essential hypertension","volume":"26","author":"Dohi","year":"2003","journal-title":"Hypertens. Res."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100782_bb3035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/oby.2007.546","article-title":"Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects","volume":"15","author":"Sutherland","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.ahjo.2026.100782_bb3040","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/oby.2008.252","article-title":"Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants","volume":"16","author":"Peairs","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"10.1016\/j.ahjo.2026.100782_bb3045","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jacc.2005.06.078","article-title":"Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients","volume":"46","author":"Ruano","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100782_bb3050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1755-5922.12072","article-title":"Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid\/laropiprant on oxidative stress markers in patients with mixed dyslipidemia","volume":"32","author":"Kei","year":"2014","journal-title":"Cardiovasc. Ther."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100782_bb3055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2337\/dc11-1255","article-title":"Effect of \u03b1-lipoic acid on platelet reactivity in type 1 diabetic patients","volume":"35","author":"Mollo","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ahjo.2026.100782_bb3060","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.2337\/dc13-0750","article-title":"Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes","volume":"36","author":"Ceriello","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100782_bb3065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00592-014-0629-4","article-title":"Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation","volume":"52","author":"Tassone","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ahjo.2026.100782_bb3070","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6423987","article-title":"A randomized study to compare the effects of once-weekly dulaglutide injection and once-daily glimepiride on glucose fluctuation of type 2 diabetes mellitus patients: a 26-week follow-up","volume":"2019","author":"Li","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ahjo.2026.100782_bb3075","article-title":"Analysis of the volatile organic compounds of epidural analgesia-ameliorated metabolic disorder in pregnant women with gestational diabetes mellitus based on untargeted metabolomics","volume":"14","author":"Si Ri","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.ahjo.2026.100782_bb3080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1160\/TH14-07-0571","article-title":"Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation","volume":"113","author":"Pignatelli","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ahjo.2026.100782_bb3085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.07.034","article-title":"Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation","volume":"365","author":"Mo\u0142ek","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100782_bb3090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejim.2016.06.016","article-title":"Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease","volume":"33","author":"Vazzana","year":"2016","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100782_bb3095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1373\/clinchem.2004.037630","article-title":"Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study","volume":"51","author":"Gross","year":"2005","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100782_bb3100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0735-1097(01)01380-8","article-title":"Endothelium-dependent vasodilation is independent of the plasma L-arginine\/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance","volume":"38","author":"Walker","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100782_bb3105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2016.04.012","article-title":"Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function","volume":"150","author":"Carnevale","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ahjo.2026.100782_bb3110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2016.07.028","article-title":"Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes","volume":"120","author":"Lipsky","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100782_bb3115","article-title":"Letter by Tsuda regarding article, \"Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage\"","volume":"44","year":"2013","journal-title":"Stroke"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:32:25Z","timestamp":1777606345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":190,"alternative-id":["S2666602226000704"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100782","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of 8-iso-PGF2\u03b1 in cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100782"}}